This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
This was a retrospective cohort study, carried out in a single centre. The duration of the follow-up was 1 month after operation (by telephone contact to the patients or the referring physicians). Loss to follow-up was not reported. In all patients, indications for stenting were elective, in that the operator elected to use stenting before starting the procedure. The study comparisons excluded all patients with multi-vessel disease who were traditionally less suitable for direct stenting. Two senior PTCA (percutaneous transluminal coronary angioplasty) operators independently reviewed coronary angiograms to identify suitable candidates for direct stenting without predilation.
Analysis of effectiveness
The analysis was based on treatment completers only. The health outcome measures were; success rate, residual stenosis and minimal lumen diameter after stent deployment, the presence of residual dissection, procedure time, radiation exposure time, contrast dye used, and any in-hospital major adverse cardiac event (MACE) (i.e., death, Q and non-Q wave myocardial infarction, coronary artery bypass graft surgery or PTCA). Comparison of the study groups in terms of baseline characteristics showed that they were different with respect to hypertension and diabetes mellitus (more frequent in the group without predilation).
Effectiveness results
The effectiveness results were as follows:
Direct stenting was successful in 118 patients (96%).
Direct stenting was successful in all 69 patients of the intervention group (procedural success of 100%); no additional stent and/or balloon was necessary.
Angiographic success was achieved in all patients in the two groups.
Residual stenosis and minimal lumen diameter after stent deployment were not statistically different between the two groups.
No residual dissection was present in the two groups.
The mean (SD) procedure time was 45 (21) min in the intervention group and 64 (46) min in the comparator group (p<0.05); radiation exposure time was 12 (9) min in the intervention group and 16 (10) No acute or subacute complications occurred in either of the two study groups one month after the procedure.
Clinical conclusions
The main finding that emerges from this single-centre study is that direct coronary stenting without predilation is a feasible and safe therapeutic approach.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis, and only separate clinical outcomes were reported. direct stent implantation without predilation was deemed to be more demanding than the conventional procedure, and more experience was perceived to be required with this new method. The study groups were comparable in terms of baseline demographic and clinical characteristics, except for hypertension and diabetes mellitus, which were more frequent in the intervention group. It was further noted that the study had no cases of incomplete balloon and stent expansion in a calcified lesion (as a potential limitation of the direct stenting approach), because of exclusion of lesions with severe calcification and the study sample being quite small. It was acknowledged that the possibility of the smaller lumen cross-sectional area in the direct stenting compared to the conventional method (as another potential limitation of the new approach) was not investigated in this study due to the fact that no intravascular ultrasound evaluation was systematically performed. The degree to which the study sample was representative of the study population cannot be assured as the authors noted that the criteria used for selecting patients suitable for primary stenting were subjective.
Validity of estimate of measure of benefit
The authors did not derive a summary measure of health benefit and, as such, the study was a cost-consequences analysis. The main benefit may be proxied through shorter exposure time to radiation through the intervention.
Validity of estimate of costs
The validity of the cost results may have been enhanced by the following positive features of the cost analysis: most quantities were reported separately from the costs; adequate details of methods of cost estimation were given; the price year was reported; and statistical analyses were performed on most resource consumption and cost data. However, the following limitations may have adversely affected the validity of the cost results: the perspective adopted in the cost analysis was not specified; the effects of alternative procedures on indirect costs were not addressed; and cost results may not be generalisable outside the study setting.
Other issues
The authors' conclusions may need to be treated with some caution due to the inherent limitations of the study design. Regarding the issue of generalisability to other settings or countries, it should be noted that cost effectiveness data are difficult to verify in the absence of sensitivity analysis. Some comparisons, however, were made with other studies. The representativeness of the study sample of the study population was, in part, addressed by acknowledging that the criteria used for selecting patients suitable for primary stenting were subjective.
Implications of the study
Other studies are needed to verify the impact of direct stenting on restenosis rates and long-term clinical outcomes.
Source of funding
None stated.
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